Expect to See Enoxaparin in Pregnant Women at Risk for Thromboembolism

December 2016

You'll hear more about PREVENTING venous thromboembolism (VTE) during pregnancy...due to new expert guidance.

Watch for women who are at risk during pregnancy and after giving birth...such as those with a clotting disorder or previous VTE.

In most cases, recommend PROPHYLACTIC low-molecular-weight heparin (LMWH) doses...such as enoxaparin 40 mg daily or 40 mg BID in obese women.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote